"HTLV-I Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.
| Descriptor ID |
D015490
|
| MeSH Number(s) |
C02.782.815.200.470 C20.673.483.470
|
| Concept/Terms |
HTLV-I Infections- HTLV-I Infections
- HTLV I Infections
- Human T-lymphotropic Virus 1 Infections
- Human T lymphotropic Virus 1 Infections
- Human T-lymphotropic Virus 1 Infection
- Human T lymphotropic Virus 1 Infection
- Infections, HTLV-I
- HTLV-I Infection
- Infection, HTLV-I
- Infections, HTLV I
|
Below are MeSH descriptors whose meaning is more general than "HTLV-I Infections".
Below are MeSH descriptors whose meaning is more specific than "HTLV-I Infections".
This graph shows the total number of publications written about "HTLV-I Infections" by people in this website by year, and whether "HTLV-I Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HTLV-I Infections" by people in Profiles.
-
Springer LE, Patton JB, Zhan T, Rabson AB, Lin HC, Manser T, Lok JB, Hess JA, Abraham D. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth. PLoS Negl Trop Dis. 2021 07; 15(7):e0009559.
-
Choksi TT, Madison G, Dar T, Asif M, Fleming K, Clarke L, Danilewitz M, Hennawy R. Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment. Am J Trop Med Hyg. 2016 Oct 05; 95(4):864-867.
-
Ratner L, Rauch D, Abel H, Caruso B, Noy A, Barta SK, Parekh S, Ramos JC, Ambinder R, Phillips A, Harding J, Baydoun HH, Cheng X, Jacobson S. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer J. 2016 Mar 25; 6:e408.
-
Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A. 1998 Jun 23; 95(13):7568-73.
-
Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant JC, Ozden S. IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol. 1995 Dec; 77(3):282-90.